Clinical Trials Browser

Phase 1/2 × Melanoma × Valproic Acid × Clear all

NCT00358319 2013-11-25

Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

Phase 1/2 Terminated

Melanoma, Neoplasm Metastasis